← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Regeneron Pharmaceuticals, Inc.
Tarrytown, NY
$25,346,919
Total funding
1
Grants
Funding over time
peak $5.3M · FY2006–10$10M$7.5M$5M$2.5M$0
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$25,346,919 · 1
By mechanism
U01$25,346,919 · 1
Investigators at Regeneron Pharmaceuticals, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Production of Targeted Null Mutations for 10,000 Genes in C57BL/6 ES Cells$5,311,300
U01 · FY2006 · HG
Production of Targeted Null Mutations for 10,000 Genes in C57BL/6 ES Cells$5,172,790
U01 · FY2008 · HG
Production of Targeted Null Mutations for 10,000 Genes in C57BL/6 ES Cells$5,094,520
U01 · FY2010 · HG
Production of Targeted Null Mutations for 10,000 Genes in C57BL/6 ES Cells$4,689,520
U01 · FY2009 · HG
Production of Targeted Null Mutations for 10,000 Genes in C57BL/6 ES Cells$4,614,400
U01 · FY2007 · HG
Production of Targeted Null Mutations for 10,000 Genes in C57BL/6 ES Cells$464,389
U01 · FY2009 · HG